M125. DISEASE PREVALENCE, COMORBID CONDITIONS, AND MEDICATION UTILIZATION AMONG PATIENTS WITH SCHIZOPHRENIA IN THE UNITED STATES

BACKGROUND: The comorbid medical and psychiatric burden for individuals with schizophrenia in the United States is substantial compared with the general population. This study sourced the IBM® MarketScan® Research Databases to examine disease prevalence, comorbid conditions, and drug treatments in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Brittany, Li, Jianheng, Lally, Cathy, Shah, Ankitaben, Bloomgren, Gary, Wenten, Made
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Session II
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234763/
http://dx.doi.org/10.1093/schbul/sbaa030.437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234763/
http://dx.doi.org/10.1093/schbul/sbaa030.437

Ejemplares similares